Tryptophan in Nutrition and Health
Tryptophan is a rate-limiting essential amino acid and a unique building block of peptides and proteins. This largest amino acid serves as the precursor for the important endogenous indoleamines serotonin, N-acetylserotonin, and melatonin that act as neurotransmitters, neuromodulators, and neurohorm...
Saved in:
Other Authors: | |
---|---|
Format: | Electronic Book Chapter |
Language: | English |
Published: |
Basel
MDPI - Multidisciplinary Digital Publishing Institute
2023
|
Subjects: | |
Online Access: | DOAB: download the publication DOAB: description of the publication |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
LEADER | 00000naaaa2200000uu 4500 | ||
---|---|---|---|
001 | doab_20_500_12854_98935 | ||
005 | 20230405 | ||
003 | oapen | ||
006 | m o d | ||
007 | cr|mn|---annan | ||
008 | 20230405s2023 xx |||||o ||| 0|eng d | ||
020 | |a books978-3-0365-7076-1 | ||
020 | |a 9783036570778 | ||
020 | |a 9783036570761 | ||
040 | |a oapen |c oapen | ||
024 | 7 | |a 10.3390/books978-3-0365-7076-1 |c doi | |
041 | 0 | |a eng | |
042 | |a dc | ||
072 | 7 | |a M |2 bicssc | |
072 | 7 | |a MMG |2 bicssc | |
100 | 1 | |a Poeggeler, Burkhard |4 edt | |
700 | 1 | |a Poeggeler, Burkhard |4 oth | |
245 | 1 | 0 | |a Tryptophan in Nutrition and Health |
260 | |a Basel |b MDPI - Multidisciplinary Digital Publishing Institute |c 2023 | ||
300 | |a 1 electronic resource (324 p.) | ||
336 | |a text |b txt |2 rdacontent | ||
337 | |a computer |b c |2 rdamedia | ||
338 | |a online resource |b cr |2 rdacarrier | ||
506 | 0 | |a Open Access |2 star |f Unrestricted online access | |
520 | |a Tryptophan is a rate-limiting essential amino acid and a unique building block of peptides and proteins. This largest amino acid serves as the precursor for the important endogenous indoleamines serotonin, N-acetylserotonin, and melatonin that act as neurotransmitters, neuromodulators, and neurohormones. Kynurenic acid is the most potent endogenous antiexitotoxic agent. Other highly relevant pathways of tryptophan are the reversible transamination to indole-3-pyruvate with formation related indolic acids that act as potent antioxidant agents. Tryptophan metabolites, such as melatonin, and structurally related agents, such as indole-3-propionic acid, act as potent catalytic antioxidants and bioenergetic agents that facilitate regeneration and protection against stress and aging. Several indole compounds act as uremic toxins since these agents can induce radical formation that is associated with enhanced oxidative stress and damage. The exploration of the effects of these protective and toxic tryptophan derived agents has revealed important molecular mechanisms and mediators of adaptation and aging. Research on tryptophan in nutrition and health can facilitate the development of new approaches to extend human health and life span. Amino acids are the building blocks of life that enable repair, as well as recycling and regeneration. Research on nutrients like amino acids, such as tryptophan and its metabolites, as well as peptides and proteins, or extracts containing this molecular metabolism modifiers can improve health. Research into the indololome is a new emerging and rapidly growing field of utmost relevance to science and society. | ||
540 | |a Creative Commons |f https://creativecommons.org/licenses/by/4.0/ |2 cc |4 https://creativecommons.org/licenses/by/4.0/ | ||
546 | |a English | ||
650 | 7 | |a Medicine |2 bicssc | |
650 | 7 | |a Pharmacology |2 bicssc | |
653 | |a tryptophan | ||
653 | |a kynurenine | ||
653 | |a kynurenic acid | ||
653 | |a FICZ | ||
653 | |a AhR | ||
653 | |a melanoma | ||
653 | |a proliferation | ||
653 | |a cell death | ||
653 | |a aryl hydrocarbon receptor | ||
653 | |a chronic kidney disease | ||
653 | |a developmental origins of health and disease (DOHaD) | ||
653 | |a hypertension | ||
653 | |a indole | ||
653 | |a melatonin | ||
653 | |a serotonin | ||
653 | |a uremic toxin | ||
653 | |a virus | ||
653 | |a immunity | ||
653 | |a codon | ||
653 | |a depression | ||
653 | |a chronic mild stress | ||
653 | |a oxidative stress | ||
653 | |a tryptophan catabolites pathway | ||
653 | |a methylation | ||
653 | |a expression | ||
653 | |a escitalopram | ||
653 | |a 5-hydroxytryptophan | ||
653 | |a natural sources | ||
653 | |a microbial production | ||
653 | |a biosynthetic pathways | ||
653 | |a physiological effects | ||
653 | |a animal | ||
653 | |a human | ||
653 | |a kynurenine pathway | ||
653 | |a MEL biosynthesis | ||
653 | |a Saccharomyces cerevisiae | ||
653 | |a yeast | ||
653 | |a tryptophan extraction | ||
653 | |a LC-MS/MS | ||
653 | |a soybean | ||
653 | |a skin | ||
653 | |a atopic dermatitis | ||
653 | |a psoriasis | ||
653 | |a severe acute respiratory syndrome | ||
653 | |a SARS-CoV-2 | ||
653 | |a COVID-19 | ||
653 | |a malignant melanoma | ||
653 | |a urine | ||
653 | |a autofluorescence | ||
653 | |a transplantation | ||
653 | |a ischemia-reperfusion | ||
653 | |a tolerance | ||
653 | |a rejection | ||
653 | |a indoleamine-2,3-dioxygenase | ||
653 | |a L-tryptophan | ||
653 | |a amino acids | ||
653 | |a MAC-T cell | ||
653 | |a proteomics | ||
653 | |a omics | ||
653 | |a β-casein | ||
653 | |a mTOR | ||
653 | |a systemic inflammation | ||
653 | |a dysbiosis | ||
653 | |a gut | ||
653 | |a microbiota | ||
653 | |a obesity | ||
653 | |a mice | ||
653 | |a tyrosine | ||
653 | |a cytokines | ||
653 | |a behavior | ||
653 | |a inflammation | ||
653 | |a liver morphology | ||
653 | |a color | ||
653 | |a cell culture media | ||
653 | |a LC-MS | ||
653 | |a antioxidant | ||
653 | |a cytotoxicity | ||
653 | |a biomanufacturing | ||
653 | |a 5-hydroxytryptamine | ||
653 | |a secretion | ||
653 | |a metabolism | ||
653 | |a nitrofurantoin | ||
653 | |a antibiotics | ||
653 | |a human serum albumin | ||
653 | |a molecular interactions | ||
653 | |a FTIR | ||
653 | |a fluorescence | ||
653 | |a n/a | ||
856 | 4 | 0 | |a www.oapen.org |u https://mdpi.com/books/pdfview/book/6988 |7 0 |z DOAB: download the publication |
856 | 4 | 0 | |a www.oapen.org |u https://directory.doabooks.org/handle/20.500.12854/98935 |7 0 |z DOAB: description of the publication |